全文获取类型
收费全文 | 1328篇 |
免费 | 77篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 28篇 |
妇产科学 | 12篇 |
基础医学 | 149篇 |
口腔科学 | 11篇 |
临床医学 | 176篇 |
内科学 | 299篇 |
皮肤病学 | 27篇 |
神经病学 | 36篇 |
特种医学 | 153篇 |
外科学 | 216篇 |
综合类 | 48篇 |
预防医学 | 45篇 |
眼科学 | 19篇 |
药学 | 110篇 |
中国医学 | 4篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 8篇 |
2022年 | 6篇 |
2021年 | 24篇 |
2020年 | 14篇 |
2019年 | 16篇 |
2018年 | 38篇 |
2017年 | 24篇 |
2016年 | 35篇 |
2015年 | 47篇 |
2014年 | 68篇 |
2013年 | 95篇 |
2012年 | 82篇 |
2011年 | 101篇 |
2010年 | 79篇 |
2009年 | 71篇 |
2008年 | 53篇 |
2007年 | 127篇 |
2006年 | 65篇 |
2005年 | 51篇 |
2004年 | 38篇 |
2003年 | 30篇 |
2002年 | 26篇 |
2001年 | 29篇 |
2000年 | 25篇 |
1999年 | 19篇 |
1998年 | 39篇 |
1997年 | 36篇 |
1996年 | 31篇 |
1995年 | 24篇 |
1994年 | 26篇 |
1993年 | 21篇 |
1992年 | 9篇 |
1991年 | 10篇 |
1990年 | 14篇 |
1989年 | 18篇 |
1988年 | 24篇 |
1987年 | 11篇 |
1986年 | 5篇 |
1985年 | 8篇 |
1984年 | 4篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 8篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1961年 | 3篇 |
1958年 | 14篇 |
1955年 | 4篇 |
排序方式: 共有1521条查询结果,搜索用时 31 毫秒
51.
52.
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas 总被引:7,自引:0,他引:7
53.
Kyo Chul Koo Hanna Yoo Tae Young Shin Jongchan Kim Young Deuk Choi Koon Ho Rha Won Sik Ham 《World journal of urology》2014,32(1):249-255
Purpose
To confirm predictive accuracies of the RENAL nephrometry score (RNS) nomogram for identifying malignancy and high-grade renal cell carcinoma (RCC) in an external cohort of small renal masses (SRMs).Methods
A total of 1,129 patients who underwent extirpative renal surgery for solid and enhancing cT1 renal tumors between 2005 and 2012 at a single institution were included in the validation cohort. A single uro-radiologist utilized computed tomography image reconstruction to classify tumors according to the RNS. The area under the curve (AUC) and calibration plots were used to determine predictive accuracies of malignancy and high-grade models of the RNS nomogram.Results
Malignant and high-grade tumors were identified in 1,012 (89.6 %) and 389 (38.4 %) patients with cT1 tumors, and in 658 (87.3 %) and 215 (32.6 %) patients with cT1a tumors, respectively. Predictive performances of the nomogram for malignancy and high-grade models revealed AUCs of 0.722 and 0.574 for cT1 tumors, and 0.727 and 0.495 for cT1a tumors, respectively. The predictive value of the malignancy model was comparable to that of the model-development cohort (AUC = 0.76); however, the predictive value of the high-grade model was inferior to that of the model-development cohort (AUC = 0.73).Conclusions
Unlike previous validation studies, we report inferior predictive performance of the RNS nomogram for discriminating high-grade RCC in solid and enhancing SRMs. This suggests that the RNS nomogram may be unreliable for preoperatively predicting high-grade RCC in SRMs, in which tumor size, the key determinant of high-grade RCC, is a limiting factor. 相似文献54.
Kyo Chul Koo Young Eun Yoon Koon Ho Rha Byung Ha Chung Seung Choul Yang Sung Joon Hong 《International urology and nephrology》2014,46(10):1935-1940
Purpose
The purpose of this study was to determine the impact of obesity on clinicopathological features and biochemical recurrence (BCR) following radical prostatectomy (RP) in Korean prostate cancer (PCa) patients.Methods
A single-institutional retrospective analysis was performed on 880 PCa patients treated by RP without neoadjuvant therapy between July 2005 and December 2011. Patients were stratified according to body mass index (BMI) standards for Asian populations: obese (BMI ≥25 kg/m2), overweight (BMI 23–24.9 kg/m2), or normal weight (BMI <23 kg/m2). For analysis, overweight and obese patients were combined (n = 592, BMI ≥23 kg/m2) and compared with normal weight patients (n = 288, BMI <23 kg/m2). BCR was defined as prostate-specific antigen (PSA) ≥0.2 ng/ml following RP.Results
Normal weight patients tended to be classified into the higher D’Amico risk category with smaller prostate volumes compared with obese and overweight patients. Normal weight patients had higher pathological Gleason scores and were at higher risk of BCR during the mean follow-up of 58.2 months. This translated to a higher 5-year BCR-free survival rate for obese and overweight patients compared with normal weight patients (77.8 vs. 70.3 %; p = 0.017). On multiple Cox-proportional hazards regression analysis incorporating variables of BMI category, PSA, positive surgical margins, pathological T stage, and Gleason score, higher BMI category remained a significant predictor of a lower risk of BCR (HR = 0.634, p = 0.028).Conclusions
Obese and overweight Korean PCa patients have lower Gleason scores and a reduced risk of BCR compared with normal weight patients. These findings suggest that body fat influences pathological features and oncologic outcomes of PCa. 相似文献55.
Daniel Y.C. Heng J. Connor Wells Brian I. Rini Benoit Beuselinck Jae-Lyun Lee Jennifer J. Knox Georg A. Bjarnason Sumanta Kumar Pal Christian K. Kollmannsberger Takeshi Yuasa Sandy Srinivas Frede Donskov Aristotelis Bamias Lori A. Wood D. Scott Ernst Neeraj Agarwal Ulka N. Vaishampayan Sun Young Rha Jenny J. Kim Toni K. Choueiri 《European urology》2014
Background
The benefit of cytoreductive nephrectomy (CN) for overall survival (OS) is unclear in patients with synchronous metastatic renal cell carcinoma (mRCC) in the era of targeted therapy.Objective
To determine OS benefit of CN compared with no CN in mRCC patients treated with targeted therapies.Design, setting, and participants
Retrospective data from patients with synchronous mRCC (n = 1658) from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) were used to compare 982 mRCC patients who had a CN with 676 mRCC patients who did not.Outcome measurements and statistical analysis
OS was compared and hazard ratios (HRs) adjusted for IMDC poor prognostic criteria.Results and limitations
Patients who had CN had better IMDC prognostic profiles versus those without (favorable, intermediate, or poor in 9%, 63%, and 28% vs 1%, 45%, and 54%, respectively). The median OS of patients with CN versus without CN was 20.6 versus 9.5 mo (p < 0.0001). When adjusted for IMDC criteria to correct for imbalances, the HR of death was 0.60 (95% confidence interval, 0.52–0.69; p < 0.0001). Patients estimated to survive <12 mo may receive marginal benefit from CN. Patients who have four or more of the IMDC prognostic criteria did not benefit from CN. Data were collected retrospectively.Conclusions
CN is beneficial in synchronous mRCC patients treated with targeted therapy, even after adjusting for prognostic factors. Patients with estimated survival times <12 mo or four or more IMDC prognostic factors may not benefit from CN. This information may aid in patient selection as we await results from randomized controlled trials.Patient summary
We looked at the survival outcomes of metastatic renal cell carcinoma patients who did or did not have the primary tumor removed. We found that most patients benefited from tumor removal, except for those with four or more IMDC risk factors. 相似文献56.
57.
58.
59.
The color complementation assay (CCA) is a method of allele-specific DNA amplification by which competitive priming and extension of fluorescently labeled oligonucleotide primers determine the color of DNA amplification product. This diagnostic method precludes the need for radioisotopes, electrophoresis, and multiple high-stringency reaction conditions. The multiplicity of mutant globin genes present in Southeast Asians complicates clinical diagnosis and underscores the importance of DNA-based diagnostic methods. We have applied CCA to distinguish beta A and beta E alleles. Competing 15mer primers were a fluorescein-labeled complement to beta A and a rhodamine-labeled complement to beta E, identical except for their central nucleotides. A common unlabeled primer was used to amplify DNA product, the color of which was determined by the perfectly complementary primer. Color photography and spectrofluorometry, as well as a method of black-white photography that we developed to distinguish fluorescein- and rhodamine- labeled DNA, were used to record results. We applied CCA to define the complex genotype of a Thai woman with thalassemia intermedia, 96% HbE, and 4% HbF whose possible genotypes included several permutations of alpha-thalassemia, beta-thalassemia, and beta E genes. zeta-Globin gene mapping of DNA doubly digested with Bg/II and Asp 718 showed the -alpha 3.7/--SEA genotype, and CCA confirmed homozygous beta E/beta E. The CCA is useful for diagnosing the compound hemoglobin genotypes of Southeast Asians and could be applied also to prenatal diagnosis in this population. 相似文献
60.
Diagnostic role of an immunoassay-detected polymorphism of factor IX for potential carriers of hemophilia B 总被引:3,自引:1,他引:3
In hemophilia B, assays based on a monoclonal antifactor IX specific for the Thr-148 variant of an exonic polymorphism have diagnosed carriers in selected families by either establishing linkage or by indicating the presence or absence of a given normal factor IX. The sensitivity of the immunoassays for detecting heterozygous women was explored by comparing results from immunoassays with solid-phase polyclonal v the monoclonal antifactor IXs. Factor IX with the normal Ala-148 variant gave a flat dilution curve, qualitatively distinct from factor IX with the Thr-148 variant in the monoclonal assay. The two were indistinguishable in the polyclonal assay. Mixtures of equal amounts of the two types gave an intermediate result, about half as reactive in the monoclonal as compared with the polyclonal assay system. Whereas mixtures with 10% Ala-148 and 90% Thr-148 factor IXs could not readily be distinguished from Thr-148 factor IX plasma, as little as 1% of the Thr-148 protein was detected in Ala-148 factor IX plasma. The frequency of the Ala-148 variant varied in individuals with different ethnic backgrounds; it was found in 29% of white, 12% of black, and none of Asian blood donors' factor IX genes in Seattle. Only 4% of samples from South African black men were nonreactive (ie, Ala- 148). The Thr/Ala-148 dimorphism is in strong linkage disequilibrium with Taql restriction fragment length polymorphisms (RFLPs). Three recombinations were noted in normal white genes and one in a normal black factor IX gene (less than 2% of those examined). In 34 white families with at least one woman being a possible carrier, genetically, the immunoassay results were informative in 18. RFLP analyses were informative in eight of the 15 families tested. In five families each, assignment of carrier status was made to a woman by only DNA or only immunoassay results, whereas the other approach was noninformative. The immunoassays provide a rapid, inexpensive screening test and complement DNA analysis in white women who are potential carriers of hemophilia B. 相似文献